Stockreport

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders [Yahoo! Finance]

Inotiv, Inc.  (NOTV) 
PDF Sea's lead molecule SPM-0404 is a potential new oral treatment in investigational new drug (IND)-enabling studies for constant bothersome tinnitus, epilepsy, and sporad [Read more]